Ana Paula Oliveira Tomaz

Ms. Ana Paula Oliveira Tomaz


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
KNKEITE da Silva NOGUEIRA
KEITE da Silva NOGUEIRA
ATAna Paula Oliveira Tomaz
Ana Paula Oliveira Tomaz
GKGabrielly Cristina Kubis
Gabrielly Cristina Kubis
RMRaizza Zorman Marques
Raizza Zorman Marques
NWNicole Geraldine de Paula Marques Witt
Nicole Geraldine de Paula Marques Witt
MGMarcelo Pedrosa Gomes
Marcelo Pedrosa Gomes
Background/Objectives: The increasing presence of antimicrobial residues and antibiotic-resistant bacteria (ARB) in effluents from wastewater treatment plants (WWTP) has become a critical concern for environmental and public health. This study aimed to investigate the occurrence, concentrations, and ecological risks of commonly used antimicrobials as well as the prevalence of clinically relevant ARB in treated effluents. Methods: A five-month monitoring campaign was conducted at a major WWTP in Curitiba, Brazil. Thirteen antibiotics were quantified using LC-MS/MS, resistant bacteria were identified via phenotypic profiling, and ecotoxicological assays were performed with Desmodesmus subspicatus. Risk assessments included hazard quotient (HQ) calculations for ecotoxicity and resistance selection as well as multivariate and correlation analyses. Results: All antibiotics were consistently detected over five months, with total concentrations ranging from 1730 to 2840 ng L−1. Clinically relevant ARB (Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae) resistant to high-priority antibiotics were also isolated. Ecotoxicological tests showed moderate growth inhibition only in undiluted effluent. HQ values for ecotoxicity were <1, but HQ for resistance selection exceeded 1 for all compounds. Multivariate analyses showed strong associations between fluoroquinolone and macrolide concentrations and ARB detection. Conclusions: Although WWTPs reduce pollutant loads, conventional processes may not fully eliminate antimicrobials and ARB, highlighting the need for advanced treatments. Culture-based detection may have underestimated the resistance diversity. These findings support the integration of resistance-based discharge thresholds into regulations, and provide a replicable model for AMR surveillance in tropical urban systems.

3 September 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
DSDilair Camargo de Souza
Dilair Camargo de Souza
LCLaura Lucia Cogo
Laura Lucia Cogo
LDLIBERA MARIA DALLA-COSTA
LIBERA MARIA DALLA-COSTA
ATAna Paula Oliveira Tomaz
Ana Paula Oliveira Tomaz
DCDanieli Conte
Danieli Conte
JPJussara Kasuko Palmeiro
Jussara Kasuko Palmeiro
Similar findings have not yet been reported in Brazil, emphasizing the importance of monitoring small-colony variants (SCVs). Altogether, our results highlight the need to improve detection methods and review antimicrobial therapy protocols in cystic fibrosis (CF) patients.

3 March 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ATAna Paula Oliveira Tomaz
Ana Paula Oliveira Tomaz
SRSonia Mara Raboni
Sonia Mara Raboni
GKGislene Maria Botão Kussen
Gislene Maria Botão Kussen
KNKEITE da Silva NOGUEIRA
KEITE da Silva NOGUEIRA
CRClea Elisa Lopes Ribeiro
Clea Elisa Lopes Ribeiro
LDLIBERA MARIA DALLA-COSTA
LIBERA MARIA DALLA-COSTA
Xpert®MTB/RIF has been widely used for tuberculosis (TB) diagnosis in Brazil, since 2014. This prospective observational study aimed to evaluate the performance of Xpert in different contexts during a two-year period: (i) laboratory and clinical/epidemiological diagnosis; (ii) HIV-positive and -negative populations; (iii) type of specimens: pulmonary and extrapulmonary. Overall, 924 specimens from 743 patients were evaluated. The performance of the assays was evaluated considering culture (Lowenstein Jensen or LJ medium) results and composite reference standard (CRS) classification as gold standard. According to CRS evaluation, 219 cases (29.5%) were classified as positive cases, 157 (21.1%) as ‘possible TB’, and 367 (49.3%) as ‘not TB’. Based on culture, Xpert and AFB smear achieved a sensitivity of 96% and 62%, respectively, while based on CRS, the sensitivities of Xpert, AFB smear, and culture were 40.7%, 20%, and 25%, respectively. The pooled sensitivity and specificity of Xpert were 96% and 94%, respectively. Metric evaluations were similar between pulmonary and extrapulmonary samples against culture, whereas compared to CRS, the sensitivities were 44.6% and 29.3% for the pulmonary and extrapulmonary cases, respectively. The Xpert detected 42/69 (60.9%) patients with confirmed TB and negative culture on LJ medium, and 52/69 (75.4%) patients with negative AFB smear results. There was no significant difference in the diagnostic accuracy based on the types of specimens and population (positive- and negative-HIV). Molecular testing detected 13 cases of TB in culture-negative patients with severe immunosuppression. Resistance to rifampicin was detected in seven samples. Herein, Xpert showed improved detection of pulmonary and extrapulmonary TB cases, both among HIV-positive and -negative patients, even in cases with advanced immunosuppression, thereby performing better than multiple other diagnostic parameters.

18 September 2024 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
ATAna Paula Oliveira Tomaz
Ana Paula Oliveira Tomaz
DSDilair Camargo de Souza
Dilair Camargo de Souza
LCLaura Lucia Cogo
Laura Lucia Cogo
JPJussara Kasuko Palmeiro
Jussara Kasuko Palmeiro
KNKEITE da Silva NOGUEIRA
KEITE da Silva NOGUEIRA
LDLIBERA MARIA DALLA-COSTA
LIBERA MARIA DALLA-COSTA
Objective: Thymidine-dependent small-colony variants (TD-SCVs) of Staphylococcus aureus are being isolated with increasing frequency from patients with cystic fibrosis (CF). The aim of this study was to evaluate the relationship between TD-SCV isolation and pulmonary function in patients with CF, as well as to determine whether the emergence of TD-SCVs was associated with trimethoprim-sulfamethoxazole (TMP-SMX) use and with coinfection with other microorganisms. Methods: This was a retrospective case-control study including patients with CF who visited the Clinical Hospital Complex of the Federal University of Paraná, in Curitiba, Brazil, between 2013 and 2022. Demographic, clinical, and spirometric data, as well as information on TD-SCVs and other isolated microorganisms, were collected from the medical records of patients with CF and TD-SCVs (TD-SCV group; n = 32) and compared with those of a matched group of patients with CF without TD-SCVs (control group; n = 64). Results: Isolation of TD-SCVs was positively associated with TMP-SMX use (p = 0.009), hospitalization (p < 0.001), and impaired pulmonary function (p = 0.04). Conclusions: The use of TMP-SMX seems to contribute to the emergence of TD-SCVs, the isolation of which was directly associated with worse pulmonary function in our sample.

26 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
DCDanieli Conte
Danieli Conte
JPJussara Kasuko Palmeiro
Jussara Kasuko Palmeiro
ABAdriane de Almeida Bavaroski
Adriane de Almeida Bavaroski
LRLuiza Souza Rodrigues
Luiza Souza Rodrigues
DCDaiane Cardozo
Daiane Cardozo
LDLIBERA MARIA DALLA-COSTA
LIBERA MARIA DALLA-COSTA
In the present study, we characterized antimicrobial resistance profile and genetic relatedness of Aeromonas spp. isolated from healthcare and urban effluents, wastewater treatment plant (WWTP), and river water. We detected the presence of genes responsible for the resistance to β-lactam, quinolone, and aminoglycoside. Enterobacterial Repetitive Intergenic Consensus PCR and multilocus sequence typing (MLST) were carried out to differentiate the strains and multilocus phylogenetic analysis (MLPA) was used to identify species. A total of 28 Aeromonas spp. cefotaxime-resistant strains were identified that carried a variety of resistance determinants, including uncommon GES-type β-lactamases. Multidrug-resistant Aeromonas spp. were found in hospital wastewater, WWTP, and sanitary effluent. Among these isolates, we detected A. caviae producing GES-1 or GES-5, as well as A. veronii harboring GES-7 or GES-16. We successfully identified Aeromonas spp. by using MLPA and found that A. caviae was the most prevalent species (85.7%). In contrast, it was not possible to determine sequence type of all isolates, suggesting incompleteness of the Aeromonas spp. MLST database. Our findings reinforce the notion about the ability of Aeromonas spp. to acquire determinants of antimicrobial resistance from the environment. Such ability can be enhanced by the release of untreated healthcare effluents, in addition to the presence of antimicrobials, recognized as potential factors for the spread of resistance. Thus, Aeromonas spp. could be included as priority pathogens under the One Health concept. IMPORTANCE: Aeromonas species are native bacteria in aquatic ecosystems worldwide. However, they have also been isolated from humans and animals. Globally, aquatic environments have been affected by anthropogenic activities. For example, the excessive use of antimicrobials in medical and veterinary practice causes the development of bacterial resistance. In addition, eliminated hospital and sanitary effluents can also serve as potential sources of bacteria carrying antimicrobial resistance genes. Thereby, impacted environments play an important role in the transmission of these pathogens, their evolution, and dissemination of genes conferring resistance to antimicrobials. Aeromonas spp. have been reported as a reservoir of antimicrobial resistance genes in the environment. In this study, we identified a great repertoire of antimicrobial resistance genes in Aeromonas spp. from diverse aquatic ecosystems, including those that encode enzymes degrading broad-spectrum antimicrobials widely used to treat healthcare-associated infections. These are a public health threat as they may spread in the population.